logo
Select company
Select metric
$ -7.04MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
33
Sector
36
Industry
37
History
15
$ 59.44Close
$ 51.75 - $ 68.52 52-Week Range
Ticker Information

Ticker

UTMD

Company Name

UTAH MEDICAL PRODUCTS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

UTAH MEDICAL PRODUCTS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

UTMD - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -7.04M
3/31/2025$ -10.48M
12/31/2024$ -9.89M
9/30/2024$ 243K
6/30/2024$ 4.6M
3/31/2024$ 12.9M
12/31/2023$ 17.82M
9/30/2023$ 18.7M
6/30/2023$ 18.39M
3/31/2023$ 15.04M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UTAH MEDICAL PRODUCTS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 8.9M.
  • Over the past 5 years, UTAH MEDICAL PRODUCTS INC's average CF - Chg. Cash has been $ 8.74M.
  • The median CF - Chg. Cash for UTAH MEDICAL PRODUCTS INC during this period was $ 9.61M
  • UTAH MEDICAL PRODUCTS INC reached its highest CF - Chg. Cash over the past 5 years at $ 18.7M.
  • The lowest CF - Chg. Cash recorded by UTAH MEDICAL PRODUCTS INC in the same timeframe $ -10.48M

UTAH MEDICAL PRODUCTS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
KRMD : KORU MEDICAL SYSTEMS INC $ -2.4MSTXS : STEREOTAXIS INC $ -8.2MTLSI : TRISALUS LIFE SCIENCES INC $ 10.01MEDIT : EDITAS MEDICINE INC $ 74.1MCCCC : C4 THERAPEUTICS INC $ 5.04MVYGR : VOYAGER THERAPEUTICS INC $ -32.19MTKNO : ALPHA TEKNOVA INC $ -15.32MMXCT : MAXCYTE INC $ -22.29MRVP : RETRACTABLE TECHNOLOGIES INC $ -3.81MPDEX : PRO DEX INC $ -2.21M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

UTMD - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -10.48M

Minimum

Mar 31, 2025

$ 18.7M

Maximum

Sep 30, 2023

$ 8.74M

Average

$ 9.61M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M